Retina Today Publishes Dr. Abbey’s Research on a Potential Toxic Side Effect of Some “Dropless” Cataract Surgery
“Dropless” cataract surgery has become more popular over the past decade and involves an injection of antibiotics and/or steroids into the eye at the time of surgery to eliminate the need for
read moreDr. Abbey Spoke About Complications of a Compounded Medication Used in “Dropless” Cataract Surgery at the Vit-Buckle Society (VBS) Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, presented “Complications of Compounded Moxifloxacin-Triamcinolone” at the 10th Annual Meeting of the Vit-Buckle Society (VBS) held March 24 – 26, 2022, in Las Vegas. He
read moreDr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video
In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in
read moreThree Texas Retina Associates Physicians Earn Honor Awards at American Society of Retina Specialists 2021 Annual Meeting
The American Society of Retina Specialists (ASRS) named Deborah Y. Chong, MD, and Robert C. Wang, MD, “Honor Awardees” at the organization’s 2021 Annual Scientific Meeting held recently in San Antonio. They
read more